• Researchers have discovered a new potential early indicator of Alzheimer's disease - changes in the retina of the eye. The study found that individuals with preclinical Alzheimer's (no cognitive symptoms yet) had thinning of the retinal nerve fiber layer, a structure in the eye that is an extension of the brain. This retinal thinning could potentially be used as a non-invasive way to detect Alzheimer's before cognitive symptoms appear.

• The study involved analyzing retinal scans of 33 individuals with preclinical Alzheimer's and 33 healthy controls. The researchers found that the preclinical Alzheimer's group had significantly thinner retinal nerve fiber layers compared to the healthy control group. This suggests that retinal changes may occur early in the Alzheimer's disease process, even before cognitive impairment is evident.

• Detecting Alzheimer's in its earliest stages is crucial, as it could allow for earlier interventions and potentially slow the progression of the disease. The researchers believe that retinal imaging could become a valuable tool for screening and monitoring Alzheimer's, as it is a quick, non-invasive, and relatively inexpensive procedure compared to other diagnostic methods like brain scans or spinal taps. Further research is needed to validate the use of retinal imaging as an Alzheimer's biomarker.